Text Size

Homburg Cream & Sugar Study (HCS)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
University Hospital, Saarland
ClinicalTrials.gov Identifier:
NCT00628524
First received: February 25, 2008
Last updated: July 19, 2011
Last verified: July 2011
History of Changes

February 25, 2008
July 19, 2011
February 2008
July 2011   (final data collection date for primary outcome measure)
Parameters of triglyceride tolerance and glucose tolerance in correlation to cardiovascular events, cardiovascular mortality, total mortality. [ Time Frame: 18 months after inclusion. ] [ Designated as safety issue: No ]
Parameters of triglyceride tolerance and glucose tolerance in correlation to cardiovascular events, cardiovascular mortality, total mortality. [ Time Frame: 6 and 12 months after inclusion. ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00628524 on ClinicalTrials.gov Archive Site
Waist-to-Hip ratio, nutrition protocol, physical activity, non-invasive endothelial function, body fat composition. [ Time Frame: Directly after inclusion. ] [ Designated as safety issue: No ]
Waist-to-Hip ratio, nutrition protocol, physical activity, non-invasive endothelial function, non-invasive hepatic fat content, body fat composition. [ Time Frame: Directly after inclusion. ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Homburg Cream & Sugar Study
Prospective Investigation of the Influence of Triglyceride Tolerance on Cardiovascular Outcomes in Patients With Coronary Artery Disease

The purpose of this study is to prospectivly analyze the correlation of triglyceride tolerance and glucose tolerance with cardiovascular morbidity and mortality in patients with stable coronary artery disease within 18 months and to determine, whether measurement of triglyceride tolerance can discriminate patients at risk for cardiovascular events.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:

Serum
Probability Sample

> 500 consecutive patients with stable coronary artery disease being treated in the cardiology department of the university hospital.
  • Coronary Artery Disease
  • Diabetes
  • Metabolic Syndrome
  • Glucose Tolerance
  • Hyperlipidemia
Not Provided
1
> 500 consecutive patients with coronary artery disease fulfilling eligibility criteria.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
500
August 2011
July 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Stable CAD

Exclusion Criteria:

  • Acute Coronary Syndrom
  • Relevant Arrhythmias
  • Severe valvular heart disease
  • Decompensated heart failure
  • Severe inflammtory disease (infectious, rheumatoid)
  • Metabolic diseases (e.g. thyroid)
  • Inability to swallow
  • Liver or kidney failure
  • Lactose intolerance
  • Fat intolerance (e.g. chronic pancreatitis, gall stones)
  • Malignant Disease
  • Psychiatric Diseases (including alcohol / drug abuse)
  • Pregnancy
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00628524
HCS Study
No
Prof. Dr. Ulrich Laufs, University Hospital of Saarland, Internal Medicine III - Cardiology, Angiology, Internal Medicine ICU
University Hospital, Saarland
Not Provided
Principal Investigator: Ulrich Laufs, MD University Hospital, Saarland
University Hospital, Saarland
July 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP